Oltipraz has an inhibitory effect on HIF-1α activation by insulin in a time-dependent manner, completely abrogating HIF-1α induction at ≥10 μM concentrations, the IC50 of Oltipraz for HIF-1α inhibition is 10 μM.Oltipraz is a potent Nrf2 activator and a potent inducer of Phase II detoxification enzymes, most notably glutathione-S-transferase (GST).
Specifications and Purity: ≥98%
MDL Number: MFCD00868499
Molecular Formula: C8H6N2S3
Molecular Weight: 226.34
EC Number: 264-736-6
PubChem CID: 47318
Isomeric SMILES: CC1=C(SSC1=S)C2=NC=CN=C2
Related Documents: https://ald-pub-files.oss-cn-shanghai.aliyuncs.com/aladdinsci/pdp/sds/1/O136690-SCI_87cc3283db33bd4129bf1aa833e759e0.pdf
- UPC:
- 41113111
- Condition:
- New
- HazmatClass:
- No
- WeightUOM:
- LB
- MPN:
- O136690-100mg
- CAS:
- 64224-21-1
- Product Size:
- 100mg
akash.verma@cenmed.com
(732) 447-1115





